Evidence map›Paper›PMID 41066419›Full record

ArticlePloS one2025

The role of lncRNA SNHG15 in UV-induced DNA damage repair.

Xin Zhang, Jiahui Lin, Zixuan Fan, Sai Zhang, Meiqi Yang, Tingting Zhu, Qing Lu, Yuming Wang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xin ZhangDepartment of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Jiahui LinDepartment of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Zixuan FanDepartment of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Sai ZhangDepartment of Neurology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Meiqi YangDepartment of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Tingting ZhuDepartment of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Qing LuDepartment of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Yuming WangDepartment of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.ORCID https://orcid.org/0000-0003-4644-4013

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aberrant expression of long noncoding RNAs (lncRNAs) serves as a critical driver in carcinogenesis and tumor evolution across various human cancers. Among these lncRNAs, small nucleolar RNA host gene 15 (SNHG15) has emerged as a key regulator in multiple cellular processes. Its dysregulation is frequently implicated in disease pathogenesis, particularly cancer. In this investigation, we delineated the functional landscape and mechanistic basis of SNHG15 in lung carcinoma. Cell cycle synchronization experiments demonstrated phase-dependent SNHG15 expression, showing maximal transcript abundance during G2/M transition. SNHG15 knockdown substantially curbed tumor growth in vitro (A549 cell line) and in vivo (subcutaneous PDX models). Notably, SNHG15 orchestrated genomic surveillance mechanisms through tripartite regulation: (1) cell cycle checkpoint coordination, (2) transcriptional machinery reactivation, and (3) nucleotide excision repair. Mechanistically, proteomic profiling coupled with RNA immunoprecipitation identified CREB5 as a direct binding partner mediating SNHG15-dependent survival signaling under genotoxic stress. These results position the SNHG15-CREB5 axis as an important player governing genomic fidelity in lung adenocarcinoma, suggesting druggable targets for precision oncology approaches.

Indexed as

DNA DamageDNA RepairLung NeoplasmsRNA, Long NoncodingUltraviolet RaysA549 CellsAnimalsCell Line, TumorCyclic AMP Response Element-Binding ProteinGene Expression Regulation, NeoplasticHumansMiceCyclic AMP Response Element-Binding ProteinRNA, Long Noncoding

Identifiers

PMID41066419
PMCPMC12510568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.